Further insights
“Immutep (ASX:IMM) plunged 35% this morning after releasing its topline results from the TACTI-003 Phase IIb Trial in First Line Head and Neck Cancer.
Source: theaustralian
IMM sinks despite cancer treatment trial success
https://search.app/Afbb9bej4bmCmzpC6
Further insights “Immutep (ASX:IMM) plunged 35% this morning...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
0.008(2.21%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 33.5¢ | $1.785M | 5.105M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 181044 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 219316 | 27 |
View Market Depth
| Last trade - 14.59pm 18/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |